Selected article for: "efficient immune control and immune control"
Author: Wisskirchen, Karin; Lucifora, Julie; Michler, Thomas; Protzer, Ulrike
Title: New pharmacological strategies to fight enveloped viruses
  • Cord-id: ali14j7x
  • Document date: 2014_8_6
    • ID: ali14j7x
    Snippet: Enveloped viruses pose an important health threat because most of the persistent and many emerging viruses are enveloped. In particular, newly emerging viruses create a need to develop broad-spectrum antivirals, which usually are obtained by targeting host cell factors. Persistent viruses have developed efficient strategies to escape host immune control, and treatment options are limited. Targeting host cell factors essential for virus persistence, or immune-based therapies provide alternative a
    Document: Enveloped viruses pose an important health threat because most of the persistent and many emerging viruses are enveloped. In particular, newly emerging viruses create a need to develop broad-spectrum antivirals, which usually are obtained by targeting host cell factors. Persistent viruses have developed efficient strategies to escape host immune control, and treatment options are limited. Targeting host cell factors essential for virus persistence, or immune-based therapies provide alternative approaches. In this review, we therefore focus on recent developments to generate antivirals targeting host cell factors or immune-based therapeutic approaches to fight infections with enveloped viruses.

    Search related documents:
    Co phrase search for related documents
    • abundant liver and low density lipoprotein: 1
    • acid complementary and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4
    • acid function and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8
    • acid function and adoptive transfer: 1
    • active immunotherapy and acute sars cov respiratory syndrome coronavirus: 1, 2
    • acute sars cov respiratory syndrome coronavirus and additional adaptation: 1, 2
    • acute sars cov respiratory syndrome coronavirus and additional adaptation require: 1
    • acute sars cov respiratory syndrome coronavirus and adoptive transfer: 1, 2, 3, 4
    • acute sars cov respiratory syndrome coronavirus and low density: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • acute sars cov respiratory syndrome coronavirus and low density lipoprotein: 1, 2, 3, 4, 5, 6, 7, 8